These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18562410)

  • 1. Rapid dose-dependent effect of clozapine on a schizophrenic patient's lipid profile.
    Chiang HL; Liu CC; Hwang TJ
    J Psychopharmacol; 2009 Jun; 23(4):465-7. PubMed ID: 18562410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
    Huang TL; Lu CY
    Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal from clozapine: the "rebound phenomenon".
    Durst R; Teitelbaum A; Katz G; Knobler HY
    Isr J Psychiatry Relat Sci; 1999; 36(2):122-8. PubMed ID: 10472746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine use and abrupt smoking cessation; a potentially life-threatening combination].
    Ruissen A; van Schaik AM; Beijnen JH
    Tijdschr Psychiatr; 2009; 51(9):699-703. PubMed ID: 19760570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium-dependent potassium permeability of cell membranes.
    Koren W; Koren E; Nacasch N; Ehrenfeld M; Gur H
    Clin Neuropharmacol; 1998; 21(4):262-4. PubMed ID: 9704170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of clozapine on glucose metabolism.
    Yazici KM; Erbas T; Yazici AH
    Exp Clin Endocrinol Diabetes; 1998; 106(6):475-7. PubMed ID: 10079027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
    Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced severe mixed hyperlipidemia: a case report.
    Ahmed M; Griffin D; O'Toole R; McDonald C
    Gen Hosp Psychiatry; 2009; 31(1):93-6. PubMed ID: 19134516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing and monitoring clozapine in Christchurch.
    McKean A; Vella-Brincat J; Begg E
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.
    Floreani J; Bastiampillai T
    Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiomyopathy associated with clozapine.
    Roh S; Ahn DH; Nam JH; Yang BH; Lee BH; Kim YS
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):94-8. PubMed ID: 16503709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of tics secondary to clozapine therapy.
    Bastiampillai T; Dhillon R; Mohindra R
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1068-70. PubMed ID: 19034993
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P; Melamed Y; Weizman A; Bleich A
    Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.
    Wysokiński A; Sobów T
    Nord J Psychiatry; 2016; 70(2):156-60. PubMed ID: 26140393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 19. The association between dyslipidaemia and types of antipsychotic medications among patients with chronic schizophrenia.
    Ruzanna ZZ; Ong LY; Cheah YC; Fairuz A; Marhani M
    Med J Malaysia; 2012 Feb; 67(1):39-44. PubMed ID: 22582547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.